Dr. Carson Discusses Mogamulizumab as Potential Treatment for CTCL
9 意见
• 08/09/23
0
0
嵌入
Kenneth R. Carson, MD, assistant professor, Division of Oncology, Washington University, discusses mogamulizumab as a potential treatment for patients with relapsed or refractory cutaneous T cell lymphoma (CTCL).
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论